FDA inspection
Biocon Limited: FDA inspection ending Jan 24, 2020
FDA inspection 1118826 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1118826 |
|---|---|
| Firm | Biocon Limited |
| FEI number | 3010164491 |
| Address | Biocon Sez Plot No. 3, Phase Iv, Bommasandra-Jigani Link Road |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Jan 24, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data